Tivic Health Systems Inc (TIVC)

$0.92 -0.01 (-0.80%)
Market Cap 1.62M
Revenue (ttm) 780,000.00
Net Income (ttm) -5.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -725.64%
Debt to Equity Ratio 0.00
Volume 167,800
Avg Vol 261,618
Day's Range N/A - N/A
Shares Out 1.77M
Stochastic %K 27%
Beta 2.01
Analysts Strong Buy
Price Target N/A

Company Profile

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its com...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 276 6888
Address:
47685 Lakeview Blvd., Fremont, United States
urgetosurge
urgetosurge Mar. 20 at 8:07 PM
$TIVC Large T trade right after the close. Mms worked an order and booked it thereafter.
1 · Reply
urgetosurge
urgetosurge Mar. 20 at 4:48 PM
$TIVC 4 and 5 share prints up the whazoo. What a manipulated turd bird..
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 2:55 PM
$TIVC last thing they needed is a shareholder class act filing. Release the kraken!
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 2:47 PM
$TIVC if their sitting on a Barda contract, they best get to releasing the news. Legal firms would jump at the opportunity to file for failing to disclose within sec time line mandates.
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 1:54 PM
$TIVC scheduled nominal shares allocated. https://www.otcmarkets.com/filing/html?id=19270025&guid=Enx-knmJNk3aJth
0 · Reply
urgetosurge
urgetosurge Mar. 19 at 1:14 PM
$TIVC NASDAQ-listed companies must adhere to strict, prompt disclosure requirements for material events to ensure fair and orderly markets. The core requirement is that material information—anything reasonably expected to affect the security's value or influence investors—must be disclosed promptly.
0 · Reply
urgetosurge
urgetosurge Mar. 18 at 2:22 PM
$TIVC the Barda contract is a material event and required to be disclosed within 3 days. It can't be shelved until a proxy vote is affirmed in their favor. Delaying a material event is a pathway to legal liability.
1 · Reply
urgetosurge
urgetosurge Mar. 17 at 8:26 PM
$TIVC we're all set here. The time release is the only variable. https://stockcharts.com/sc3/ui/?s=TIVC
0 · Reply
urgetosurge
urgetosurge Mar. 17 at 3:51 PM
$TIVC last update on shares per Schwab was 2.5 million. Currently that data is absent. Proxy didn't approve the dilution. Approximately 40k shares to borrow. Possible huge short squeeze setting up here. Barda or white label contracts should get the fomo momo.
0 · Reply
urgetosurge
urgetosurge Mar. 16 at 8:05 PM
$TIVC
0 · Reply
Latest News on TIVC
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

Mar 20, 2026, 3:35 PM EDT - 13 hours ago

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

Mar 4, 2026, 8:30 AM EST - 16 days ago

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

Feb 18, 2026, 9:15 AM EST - 4 weeks ago

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting

Jan 28, 2026, 8:30 AM EST - 7 weeks ago

Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting

Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference

Jan 26, 2026, 10:10 AM EST - 7 weeks ago

Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

Jan 20, 2026, 5:50 PM EST - 2 months ago

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Jan 12, 2026, 9:00 AM EST - 2 months ago

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

Jan 8, 2026, 8:30 AM EST - 2 months ago

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

Dec 11, 2025, 9:45 AM EST - 3 months ago

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Nov 18, 2025, 8:30 AM EST - 4 months ago

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Tivic Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 4:30 PM EST - 4 months ago

Tivic Reports Third Quarter 2025 Financial Results

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

Nov 13, 2025, 8:30 AM EST - 4 months ago

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

Tivic Expands Intellectual Property Portfolio

Nov 10, 2025, 9:00 AM EST - 4 months ago

Tivic Expands Intellectual Property Portfolio

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Nov 6, 2025, 9:30 AM EST - 4 months ago

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Oct 22, 2025, 2:00 PM EDT - 5 months ago

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference

Sep 22, 2025, 8:30 AM EDT - 6 months ago

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Sep 10, 2025, 8:30 AM EDT - 6 months ago

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Aug 20, 2025, 8:30 AM EDT - 7 months ago

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Aug 15, 2025, 8:30 AM EDT - 7 months ago

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:00 PM EDT - 7 months ago

Tivic Reports Second Quarter 2025 Financial Results

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Aug 7, 2025, 8:30 AM EDT - 8 months ago

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Jun 25, 2025, 8:30 AM EDT - 9 months ago

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health Announces 2025 Annual Meeting of Stockholders

Jun 24, 2025, 8:30 AM EDT - 9 months ago

Tivic Health Announces 2025 Annual Meeting of Stockholders

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 15, 2025, 4:05 PM EDT - 11 months ago

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

May 14, 2025, 8:30 AM EDT - 11 months ago

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

Tivic Expands VNS Intellectual Property Portfolio

May 13, 2025, 8:30 AM EDT - 11 months ago

Tivic Expands VNS Intellectual Property Portfolio

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

May 9, 2025, 8:30 AM EDT - 11 months ago

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

Apr 22, 2025, 8:30 AM EDT - 11 months ago

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

Apr 10, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

Mar 21, 2025, 4:00 PM EDT - 1 year ago

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Mar 13, 2025, 4:59 PM EDT - 1 year ago

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Mar 6, 2025, 8:15 AM EST - 1 year ago

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Tivic Health Systems, Inc. Announces Reverse Stock Split

Mar 5, 2025, 8:15 AM EST - 1 year ago

Tivic Health Systems, Inc. Announces Reverse Stock Split

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Mar 3, 2025, 8:15 AM EST - 1 year ago

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Feb 24, 2025, 8:15 AM EST - 1 year ago

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

Feb 12, 2025, 8:30 AM EST - 1 year ago

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

CEO Letter to Shareholders Issued by Tivic Health

Dec 23, 2024, 4:54 PM EST - 1 year ago

CEO Letter to Shareholders Issued by Tivic Health

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 14, 2024, 11:36 PM EST - 1 year ago

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Nov 14, 2024, 8:45 AM EST - 1 year ago

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health Validates European Patents in Great Britain, Germany, and France

Nov 12, 2024, 8:30 AM EST - 1 year ago

Tivic Health Validates European Patents in Great Britain, Germany, and France

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

Nov 7, 2024, 8:30 AM EST - 1 year ago

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Oct 29, 2024, 8:00 AM EDT - 1 year ago

First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Tivic Health Accelerates VNS Commercial Strategy Development

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Accelerates VNS Commercial Strategy Development

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

Sep 13, 2024, 5:29 PM EDT - 1 year ago

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

Tivic Reports Second Quarter 2024 Financial Results

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Tivic Reports Second Quarter 2024 Financial Results

Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast

Aug 6, 2024, 9:15 AM EDT - 1 year ago

Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast

urgetosurge
urgetosurge Mar. 20 at 8:07 PM
$TIVC Large T trade right after the close. Mms worked an order and booked it thereafter.
1 · Reply
urgetosurge
urgetosurge Mar. 20 at 4:48 PM
$TIVC 4 and 5 share prints up the whazoo. What a manipulated turd bird..
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 2:55 PM
$TIVC last thing they needed is a shareholder class act filing. Release the kraken!
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 2:47 PM
$TIVC if their sitting on a Barda contract, they best get to releasing the news. Legal firms would jump at the opportunity to file for failing to disclose within sec time line mandates.
0 · Reply
urgetosurge
urgetosurge Mar. 20 at 1:54 PM
$TIVC scheduled nominal shares allocated. https://www.otcmarkets.com/filing/html?id=19270025&guid=Enx-knmJNk3aJth
0 · Reply
urgetosurge
urgetosurge Mar. 19 at 1:14 PM
$TIVC NASDAQ-listed companies must adhere to strict, prompt disclosure requirements for material events to ensure fair and orderly markets. The core requirement is that material information—anything reasonably expected to affect the security's value or influence investors—must be disclosed promptly.
0 · Reply
urgetosurge
urgetosurge Mar. 18 at 2:22 PM
$TIVC the Barda contract is a material event and required to be disclosed within 3 days. It can't be shelved until a proxy vote is affirmed in their favor. Delaying a material event is a pathway to legal liability.
1 · Reply
urgetosurge
urgetosurge Mar. 17 at 8:26 PM
$TIVC we're all set here. The time release is the only variable. https://stockcharts.com/sc3/ui/?s=TIVC
0 · Reply
urgetosurge
urgetosurge Mar. 17 at 3:51 PM
$TIVC last update on shares per Schwab was 2.5 million. Currently that data is absent. Proxy didn't approve the dilution. Approximately 40k shares to borrow. Possible huge short squeeze setting up here. Barda or white label contracts should get the fomo momo.
0 · Reply
urgetosurge
urgetosurge Mar. 16 at 8:05 PM
$TIVC
0 · Reply
focafoca99
focafoca99 Mar. 14 at 10:53 PM
$TIVC just locked in an 8,024 sq. ft. microbial facility lease in Austin.
1 · Reply
urgetosurge
urgetosurge Mar. 14 at 10:51 AM
$TIVC talk about bleeding monies on rents...wow. Property owners via rents are going to fleece this bloated pig. Over the top imo, especially with no announced revenue contracts. Yeah, without the golden goose, this operation is a drain it dry program.. https://www.otcmarkets.com/filing/html?id=19249191&guid=xfx-kenyprfYlhh
0 · Reply
urgetosurge
urgetosurge Mar. 13 at 9:26 PM
$TIVC no dilution the shorts counted on and 2.5 million shares. Where's the mother of all short squeezes? Where's the revenue contracts that impale the rug pulling pedo parasites? Hopefully they'll deliver the pain on Monday.
0 · Reply
urgetosurge
urgetosurge Mar. 13 at 4:42 PM
$TIVC this should already be at our near 2 bones. Wake the f up!!
0 · Reply
urgetosurge
urgetosurge Mar. 13 at 2:58 PM
$TIVC proxy proposals are canceled. Bring the fn contracts!!
0 · Reply
urgetosurge
urgetosurge Mar. 12 at 3:32 PM
$TIVC
0 · Reply
urgetosurge
urgetosurge Mar. 11 at 4:44 PM
$TIVC hello??
1 · Reply
urgetosurge
urgetosurge Mar. 11 at 2:10 PM
$TIVC
0 · Reply
urgetosurge
urgetosurge Mar. 10 at 9:24 PM
$TIVC shorts still in control. Banking on the proxy solutions of dilution.
1 · Reply
Nakuldesai
Nakuldesai Mar. 10 at 9:18 PM
$TIVC greatest pump and dump of all time.
0 · Reply
stockanalysis_
stockanalysis_ Mar. 10 at 8:27 PM
After Hours Losers: $CLIR $GRPN $KOS $OIO $TIVC Save this screener: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading
0 · Reply
thegoodcall
thegoodcall Mar. 10 at 7:46 PM
$TIVC $2+
1 · Reply